Dear customer, we are sorry but your browser doesn't support all necessary features for good site view. Please switch to one of the modern browsers (Chrome, Safari, Firefox).
Our CompaniesNewsroomInsights

About PPF Group

About UsPeople and statutory bodiesFinancial results & statementsReports and documents

Social responsibility

Social responsibilitySustainability
For MediaContactsCareers
cs

News to Email

Get the latest press releases, interviews, podcasts, and insights. 

Subscribe To News

Follow us

For Media

  • Press Releases
  • Interviews and Podcasts
  • Subscribe To News
  • Downloads
  • Contacts

MAY BE OF INTEREST

  • Our Companies
  • Newsroom
  • Insights

Contacts

  • PPF Group Companies
  • Terms of use
  • Data protection
  • Sitemap
  • Cookies policy

2026 © PPF Group

Most often you are looking for

Annual ReportsInsightsVisions and StrategiesPress Releases
  • Insights

  • Biotech Market / Business Intelligence

  • September 2024 Biotechnology: Review of news from the most innovative therapeutic areas and the business development transactions

Legal Notice

Sotio Biotech

15/10/2024 | 1 minute to read

Print
Copy link

Share on social networks

Share on social networks

Print

Copy link

Related articles

Sotio Biotech

15/10/2024

Slow IPO season may be coming to an end, as four biotechs completed IPO of $100+ million

Sotio Biotech

15/10/2024

Rybrevant plus chemotherapy show 49 % ORR in metastatic colorectal cancer

Sotio Biotech

15/10/2024

ArsenalBio announced $325 million financing to advance cell therapy programs

Sotio Biotech

15/10/2024

Patritumab-Dx demonstrates a statistically significant Ph 3 PFS improvement in NSCLC

Sotio Biotech

15/10/2024

ImmunityBio presented positive long-term OS data of Anktiva in NSCLC

Insights

The material contained in this document was prepared based on information from public and private sources that SOTIO believes to be reliable. It is protected by copyright law and cannot be further disseminated or used for any commercial purposes without SOTIO´s prior written consent. 

This document is distributed for general informational and educational purposes only and is not intended to constitute legal or investment advice. The information, opinions and views contained herein have not been tailored to the investment objectives of any one individual, are current only as of the date hereof and may be subject to change at any time without prior notice. SOTIO does not have any obligation to provide revised opinions in the event of changed circumstances. All investment strategies and investments involve risk of loss. 

Nothing contained in this document should be construed as investment advice. Any reference to an investment’s past or potential performance is not, and should not be construed as, a recommendation or as a guarantee of any specific outcome or profit. 

The information contained herein is not, and shall not constitute an offer to sell, a solicitation of an offer to buy or an offer to purchase any securities, nor should it be deemed to be an offer, or a solicitation of an offer, to purchase or sell any investment product or service.